Saccharomyces cerevisiae engineering strain for producing bakuchiol as well as construction method and application thereof
By constructing the Saccharomyces cerevisiae engineering strain, expressing geranyl pyrophosphate and p-coumaric acid synthesis pathways, and introducing the mutant isopentenyl transferase, the problem of unresolved psoralophenol biosynthesis pathway was solved, achieving high efficiency, Green recycled synthesis improves yield and purity.
Patent Information
- Application Number
- CN202411150718.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-21
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-21
AI Technical Summary
The biosynthesis pathway of psoralenol in the prior art has not been fully analyzed, and there are problems with unclear key enzymes, which leads to challenges in its industrial production, especially the preparation of high purity and content is difficult to achieve.
By constructing the Saccharomyces cerevisiae engineering strain, overexpressing the geranyl pyrophosphate synthesis pathway and the coumaric acid synthesis pathway, and introducing the mutant isopentenyl transferase PcPT07, the trans geranyl erythration of coumaric acid and the intercourse of coumaric acid The decarboxylation reaction can produce psoralophenol and can be synthesized de novo with glucose as a single carbon source.
The production of psoralophenol by microorganisms using exogenous coumaric acid was achieved, which improved the efficiency and yield of de novo synthesis. The fermentation yield of shake flasks can reach 9.27mg/L, solving the problem of unspecified key enzymes and achieving high efficiency. Green and environmentally friendly psoralophenol production.
Smart Images

Figure CN118909814A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the fields of biotechnology and synthetic biology technology, and specifically relates to bakuchiol-producing brewer's yeast, a construction method and an application thereof. Background Art
[0002] Bakuchiol is a terpene phenolic compound extracted and separated from the seeds of the plant Psoralea corylifolia L.Medik. It has a wide range of biological activities, such as anti-cancer, antioxidant, antibacterial, and immunosuppressive. Bakuchiol can be used as a skin protectant, skin feel regulator, moisturizer, and antioxidant. Because its efficacy is similar to that of retinol, and it is mild and stable to light, it has received increasing attention in the cosmetics field.
[0003] Like most natural products, the production of bakuchiol mainly relies on extraction from plants. However, bakuchiol coexists with other coumarins that can promote skin cancer, such as psoralen and isopsoralen, which places higher demands on the downstream purification steps. In addition, some factors such as long plant growth cycle, environmental climate requirements, and uncertain natural factors pose challenges to the supply of bakuchiol. From the perspective of organic synthesis, although the total synthesis of bakuchiol has been reported, the strict reaction conditions and the use of toxic chemical reagents limit its industrial production. Therefore, the preparation of high-purity and high-content bakuchiol is a major challenge.
[0004] The efficient heterologous synthesis of bakuchiol by microorganisms is a sustainable, green and attractive solution with considerable economic and social benefits. However, the biosynthetic pathway of bakuchiol has not been fully elucidated to date, and there are problems such as unclear key enzymes. Therefore, there is an urgent need for a bakuchiol-producing microbial cell and a method for constructing the same that can solve the above problems. Summary of the invention
[0005] In view of the deficiencies of the prior art, the present invention provides a bakuchiol-producing yeast engineering strain and a construction method and application thereof. The yeast engineering strain of the present invention can use p-coumaric acid (3-(4-hydroxyphenyl)-2-propenoic acid) as a substrate, catalyze the trans-geranylation of p-coumaric acid and couple decarboxylation to generate bakuchiol; the yeast engineering strain of the present invention can also synthesize bakuchiol from scratch using glucose as a single carbon source.
[0006] The technical solution adopted by the present invention is:
[0007] (I) An engineered strain of Saccharomyces cerevisiae producing bakuchiol
[0008] The engineered strain of Saccharomyces cerevisiae overexpresses genes in the geranyl pyrophosphate synthesis pathway, genes in the p-coumaric acid synthesis pathway and a gene encoding a mutant prenyl transferase PcPT07.
[0009] The geranyl pyrophosphate synthesis pathway genes include the gene encoding acetoacetyl-CoA thiolase / HMG-CoA reductase EfMvaE from Enterococcus faecalis and the mutant mevalonate synthase EfMvaS A110G The encoding gene, as well as the yeast-derived isopentenyl diphosphate isomerase IDI1 encoding gene, phosphomevalonate kinase ERG8 encoding gene, diphosphomevalonate decarboxylase ERG19 encoding gene, mevalonate kinase ERG12 encoding gene and geranyl pyrophosphate synthase mutant ERG20 F96W / N127W Coding gene.
[0010] The p-coumaric acid synthesis pathway genes include the phenylalanine ammonia lyase AtPAL2 encoding gene, the cinnamic acid-4-hydroxylase AtC4H encoding gene and the P450 reductase AtATR2 encoding gene from Arabidopsis thaliana, the tyrosine ammonia lyase FjTAL encoding gene from Flavobacterium johnsonii, and the mutant 3-deoxy-D-arabinoheptulose-7-phosphate synthase ARO4 from Saccharomyces cerevisiae. K229L Chorismate mutase ARO7 G141S Coding gene.
[0011] The engineered strain of Saccharomyces cerevisiae has the ability to synthesize bakuchiol de novo using glucose as a single carbon source, that is, the ability to generate bakuchiol de novo using glucose as a substrate.
[0012] Specifically, the engineered strain of Saccharomyces cerevisiae produces bakuchiol by trans-geranylation of the intermediate p-coumaric acid and coupling decarboxylation reaction.
[0013] The mutant isopentenyl transferase PcPT07 is used to catalyze the trans-geranylation of p-coumaric acid and coupled decarboxylation reaction. The mutant isopentenyl transferase PcPT07 is a truncated isopentenyl transferase PcPT07-FL. The truncation range is the first 84 amino acid sequences at the N-terminus of the isopentenyl transferase PcPT07-FL. The source of the isopentenyl transferase PcPT07-FL is psoralea corylifolia.
[0014] The engineered strain of Saccharomyces cerevisiae is introduced with the mutant isopentenyl transferase PcPT07 encoding gene by at least one of the following integration methods:
[0015] a: An expression cassette containing a gene encoding a mutant isopentenyl transferase PcPT07 is integrated into the genome of the engineered strain of Saccharomyces cerevisiae;
[0016] b: An expression cassette containing 1 to 3 fusion gene fragments is integrated into the genome of the engineered yeast strain of Saccharomyces cerevisiae. The fusion gene fragments are mainly composed of a gene encoding a mutant isopentenyl transferase PcPT07 and a gene encoding a mutant geranyl pyrophosphate synthase ERG20 through a linker. F96W / N127W The coding genes are connected.
[0017] The amino acid sequence of the mutant isopentenyl transferase PcPT07 is shown in SEQ ID NO.1.
[0018] The nucleotide sequence of the gene encoding the mutant isopentenyl transferase PcPT07 is shown in SEQ ID NO.2; the amino acid sequence of the isopentenyl transferase PcPT07-FL is shown in SEQ ID NO.15.
[0019] The nucleotide sequence of the fusion gene fragment is shown in SEQ ID NO.16; the nucleotide sequence of the connecting peptide encoding gene is shown in SEQ ID NO.17; and the amino acid sequence of the connecting peptide is shown in SEQ ID NO.18.
[0020] The engineered strain of Saccharomyces cerevisiae is also transformed by at least one of the following transformation methods:
[0021] a) in the genome of the engineered yeast strain, the endogenous pyruvate decarboxylase PDC5 encoding gene and the phenylpyruvate decarboxylase ARO10 encoding gene are knocked out;
[0022] b) In the genome of the engineered strain of Saccharomyces cerevisiae, the promoter of the gene encoding farnesyl pyrophosphate synthase ERG20 is replaced in situ with the promoter of the gene encoding squalene epoxidase ERG1.
[0023] The brewer's yeast engineered strain is classified and named as brewer's yeast (Saccharomyces cerevisiae) BAK07, with a preservation number of CGMCC NO.31081. The preservation unit is the General Microbiology Center of the China Microbiological Culture Collection Administration, with an address of No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and a preservation date of June 25, 2024. The brewer's yeast BAK07 uses brewer's yeast BY4742 as a starting strain. The genome of the brewer's yeast BAK07 integrates the geranyl pyrophosphate synthesis pathway genes, the p-coumaric acid synthesis pathway genes, the mutant isopentenyl transferase PcPT07 encoding gene and the fusion gene fragment. The genome of the brewer's yeast BAK07 also knocks out the pyruvate decarboxylase PDC5 encoding gene and the phenylpyruvate decarboxylase ARO10 encoding gene. The promoter of the farnesyl pyrophosphate synthase ERG20 encoding gene in the brewer's yeast BAK07 genome is replaced in situ with the promoter of the squalene epoxidase ERG1 encoding gene.
[0024] (II) A method for constructing an engineered strain of Saccharomyces cerevisiae that produces bakuchiol
[0025] The construction method specifically comprises: constructing multiple expression cassettes, integrating each expression cassette into different sites in the genome of Saccharomyces cerevisiae by homologous recombination technology to obtain a first strain, and using the first strain as the engineering strain;
[0026] The expression cassette includes a first expression cassette, a second expression cassette, a third expression cassette, a fourth expression cassette and a fifth expression cassette; the first expression cassette includes a phenylalanine ammonia lyase AtPAL2 encoding gene, a cinnamic acid-4-hydroxylase AtC4H encoding gene and a P450 reductase AtATR2 encoding gene; the second expression cassette includes a tyrosine ammonia lyase FjTAL encoding gene, a mutant 3-deoxy-D-arabinoheptulose acid-7-phosphate synthase ARO4 K229L Chorismate mutase ARO7 G141S encoding gene; the third expression cassette comprises the acetoacetyl-CoA thiolase / HMG-CoA reductase EfMvaE encoding gene, mutant mevalonate synthase EfMvaS A110G The fourth expression cassette comprises a gene encoding mevalonate kinase ERG12, a gene encoding phosphomevalonate kinase ERG8, and a gene encoding diphosphomevalonate decarboxylase ERG19; the fifth expression cassette comprises a mutant geranyl pyrophosphate synthase ERG20 F96W / N127W Encoding gene and mutant isopentenyl transferase PcPT07 encoding gene.
[0027] The construction method further comprises the following steps:
[0028] knocking out the endogenous pyruvate decarboxylase PDC5 encoding gene and the phenylpyruvate decarboxylase ARO10 encoding gene of Saccharomyces cerevisiae in the first strain by homologous recombination technology to obtain a second strain;
[0029] The promoter of the gene encoding farnesyl pyrophosphate synthase ERG20 in the genome of the second strain is replaced in situ with the promoter of the gene encoding squalene epoxidase ERG1 by homologous recombination technology to obtain a third strain;
[0030] The mutant isopentenyl transferase PcPT07 encoding gene is linked to the geranyl pyrophosphate synthase mutant ERG20 through a linker peptide encoding gene. F96W / N127W The coding genes are connected to obtain a fusion gene fragment; an expression cassette containing a copy of the fusion gene fragment is constructed according to the fusion gene fragment, and the expression cassette containing 1 to 3 copies of the fusion gene fragment is integrated into the genome of the third strain through homologous recombination technology to obtain a fourth strain, and the fourth strain is used as the brewer's yeast engineering strain.
[0031] (III) Application of an engineered strain of Saccharomyces cerevisiae producing bakuchiol
[0032] It is used to produce bakuchiol using glucose as a substrate and p-coumaric acid generated from glucose as an intermediate product by catalyzing the trans-geranylation of p-coumaric acid and coupling decarboxylation.
[0033] (IV) A method for producing bakuchiol using an engineered strain of Saccharomyces cerevisiae that produces bakuchiol
[0034] The engineered strain of Saccharomyces cerevisiae is cultured in a fermentation medium to obtain a fermentation culture, and the fermentation culture is extracted and separated to obtain bakuchiol.
[0035] The beneficial effects of the present invention are as follows:
[0036] 1. The present invention solves the problem of the key enzyme required for the synthesis of bakuchiol by strengthening the mevalonate pathway in Saccharomyces cerevisiae and integrating the mutant isopentenyl transferase PcPT07 encoding gene, thereby achieving the effect of synthesizing bakuchiol by utilizing exogenous p-coumaric acid through microorganisms.
[0037] 2. The present invention further integrates endogenous and exogenous genes into the genome of Saccharomyces cerevisiae, thereby achieving the effect of synthesizing bakuchiol from scratch by microorganisms using glucose as the sole carbon source.
[0038] 3. The present invention strengthens the relevant reaction pathways by knocking out endogenous genes, replacing endogenous promoters in situ, and integrating fusion proteins, thereby improving the efficiency and yield of de novo synthesis of bakuchiol by microorganisms. The shake flask fermentation yield of the engineered strain Saccharomyces cerevisiae BAK07 obtained by the above transformation methods can reach 9.27 mg / L. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Figure 1 Schematic diagram of the biosynthetic pathway of bakuchiol;
[0040] Figure 2 The liquid phase diagram for the catalytic synthesis of bakuchiol in vivo;
[0041] Figure 3 The liquid phase diagram of the in vitro catalytic synthesis of bakuchiol;
[0042] Figure 4 This is the LC-MS analysis chart of Bakuchiol in negative ion mode. DETAILED DESCRIPTION
[0043] The present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.
[0044] Unless otherwise specified, in the present invention, except for the mutant isopentenyl transferase PcPT07 (obtained by N-terminal truncation of the original protein isopentenyl transferase PcPT07-FL), the other mutant proteins are referred to as “protein name”. 第一突变位点 / 第二突变位点 / … / 第N突变位点 ". The symbol " / " between two mutation sites represents "and". For example, the geranyl pyrophosphate synthase mutant ERG20 F96W / N127W , indicating that it is derived from the F96W mutation and N127W mutation of geranyl pyrophosphate synthase ERG20. In addition, the mutation type of the protein is named in the form of "original amino acid-site number-mutated amino acid". For example, the F96W mutation means that at the 96th amino acid position of the protein, the original phenylalanine (abbreviated as F) is replaced by tryptophan (abbreviated as W).
[0045] The invention provides an engineered strain of Saccharomyces cerevisiae producing bakuchiol. The engineered strain of Saccharomyces cerevisiae has the ability to use glucose as a substrate to synthesize an intermediate product, p-coumaric acid, and to generate bakuchiol by trans-geranylation of p-coumaric acid and coupled decarboxylation. Figure 1 ).
[0046] The engineered strain of Saccharomyces cerevisiae overexpresses genes of the geranyl pyrophosphate synthesis pathway, genes of the p-coumaric acid synthesis pathway and a gene encoding a mutant prenyl transferase PcPT07.
[0047] Among them, the mutant isopentenyl transferase PcPT07 encoding gene expresses mutant isopentenyl transferase PcPT07, and the mutant isopentenyl transferase PcPT07 can catalyze the trans-geranylation of p-coumaric acid and couple decarboxylation to generate bakuchiol. The amino acid sequence of the mutant isopentenyl transferase PcPT07 is shown in SEQ ID NO.1, and the mutant isopentenyl transferase PcPT07 is a truncated isopentenyl transferase PcPT07, and the truncation range is the first 84 amino acid sequences of the N-terminus of the protein. The amino acid sequence of the isopentenyl transferase PcPT07-FL is shown in SEQ ID NO.15.
[0048] Among them, genes in the p-coumaric acid synthesis pathway include:
[0049] 1) Expressing tyrosine ammonia lyase FjTAL from Flavobacterium johnsonii, the GenBank number of the FjTAL encoding gene is WP_012023194.1; used to catalyze the process of ① generating p-coumaric acid from tyrosine ( Figure 1 );
[0050] 2) Expressing the phenylalanine ammonia lyase AtPAL2 from Arabidopsis thaliana, the GenBank number of the AtPAL2 encoding gene is NM_115186.4; used to participate in the catalysis of the process of generating p-coumaric acid from phenylalanine ( Figure 1 );
[0051] 3) Expressing cinnamic acid-4-hydroxylase AtC4H from Arabidopsis thaliana, the GenBank number of AtC4H encoding gene is NM_128601.3; used to participate in catalysis ② the process of generating p-coumaric acid from phenylalanine ( Figure 1 );
[0052] 4) Expressing the P450 reductase AtATR2 from Arabidopsis thaliana, the GenBank number of the AtATR2 encoding gene is NM_119167.4; used to participate in the catalysis of the process of generating p-coumaric acid from phenylalanine ( Figure 1 );
[0053] 5) Expression of mutant 3-deoxy-D-arabinoheptulose-7-phosphate synthase ARO4 from Saccharomyces cerevisiae K229L Chorismate mutase ARO7 G141S Encoding gene, ARO4 K229L The nucleotide sequence of the coding gene is shown in SEQ ID NO.3; ARO7 G141S The nucleotide sequence of the encoding gene is shown in SEQ ID NO. 4, and is used to improve the efficiency of converting glucose into tyrosine and glucose into phenylalanine.
[0054] Among them, the genes of geranyl pyrophosphate synthesis pathway include:
[0055] 1) Expressing acetoacetyl-CoA thiolase / HMG-CoA reductase EfMvaE from Enterococcus faecalis, the GenBank number of the EfMvaE encoding gene is KX064239; used to increase the content of geranyl pyrophosphate (GPP) ( Figure 1 );
[0056] 2) Expression of the mutant mevalonate synthase EfMvaS from Enterococcus faecalis A110G ,EfMv A110G The nucleotide sequence of the coding gene is shown in SEQ ID NO.5; used to increase the content of geranyl pyrophosphate ( Figure 1 );
[0057] 3) Expression of Saccharomyces cerevisiae-derived phosphomevalonate kinase ERG8, diphosphomevalonate decarboxylase ERG19, mevalonate kinase ERG12, isopentenyl diphosphate isomerase IDI1, and geranyl pyrophosphate synthase mutant ERG20 F96W / N127W Since the endogenous geranyl pyrophosphate content of yeast is low, the present invention introduces the above enzyme to increase the content of geranyl pyrophosphate.
[0058] The above gene is integrated into the starting strain Saccharomyces cerevisiae to construct an engineered strain of Saccharomyces cerevisiae, which has the ability to synthesize bakuchiol from scratch using glucose as a substrate.
[0059] Furthermore, based on the above-mentioned engineered strain, the endogenous pyruvate decarboxylase PDC5 encoding gene and the phenylpyruvate decarboxylase ARO10 encoding gene of Saccharomyces cerevisiae are further knocked out, which can enhance the ability of the engineered strain to ferment and produce bakuchiol by increasing the efficiency of converting glucose into tyrosine and glucose into phenylalanine.
[0060] Furthermore, since the endogenous farnesyl diphosphate synthase ERG20 in Saccharomyces cerevisiae consumes geranyl pyrophosphate, knocking out ERG20 is lethal. Therefore, based on the above-mentioned engineered strain, the ERG20 promoter can be replaced with the ERG1 promoter by in situ replacement, which can improve the ability of the engineered strain to produce bakuchiol by fermentation.
[0061] Furthermore, in order to improve the catalytic activity of mutant isopentenyl transferase PcPT07, the geranyl pyrophosphate synthase mutant ERG20 was linked to the cytosolic acid ester of 1% β-GGGGS. F96W / N127W Fusion to the N-terminus of mutant isopentenyl transferase PcPT07 to generate fusion protein ERG20 F96W / N127W -GGGGS-PcPT07. Through multi-copy integration, the fusion protein ERG20F96W / N127W - The GGGGS-PcPT07 encoding gene is integrated into the genome of the above-mentioned engineered strain, which can enhance the ability of the engineered strain to produce bakuchiol by fermentation.
[0062] The present invention also provides an engineered strain of brewer's yeast: brewer's yeast (Saccharomyces cerevisiae) BAK07. Brewer's yeast BAK07 uses brewer's yeast BY4742 as a starting strain, integrates geranyl pyrophosphate synthesis pathway genes, p-coumaric acid synthesis pathway genes, mutant isopentenyl transferase PcPT07 encoding genes and three fusion gene fragment copies, and the genome of brewer's yeast BAK07 also knocks out the pyruvate decarboxylase PDC5 encoding gene and the phenylpyruvate decarboxylase ARO10 encoding gene, and the promoter of the farnesyl pyrophosphate synthase ERG20 encoding gene in the brewer's yeast BAK07 genome is replaced in situ with the promoter of the squalene epoxidase ERG1 encoding gene. The strain can efficiently synthesize bakuchiol, and the bakuchiol yield of shake flask fermentation can reach 9.28 mg / L.
[0063] In the present invention, the geranyl pyrophosphate synthesis pathway gene, the p-coumaric acid synthesis pathway gene and the mutant isopentenyl transferase PcPT07 encoding gene are respectively integrated into different sites on the genome of Saccharomyces cerevisiae.
[0064] In the present invention, the expression cassette construction method and the integration and recombination method can be conventional methods well known to those skilled in the art.
[0065] The present invention provides a method for constructing an engineered strain capable of producing bakuchiol using exogenous p-coumaric acid, specifically comprising:
[0066] A plurality of expression cassettes are constructed by conventional methods well known to those skilled in the art, and each expression cassette is integrated into different sites in the genome of Saccharomyces cerevisiae by homologous recombination technology to obtain an engineered strain that can produce bakuchiol using exogenous p-coumaric acid. The expression cassette includes:
[0067] The third expression cassette includes constitutive promoters FBA1p, PGK1p, TEF1p; terminators VPS13t, TEF2t, CYC1t; enzymes EfMvaE and EfMvaS of the mevalonate pathway A110G , IDI1 and the upstream and downstream homology arms of the insertion site, US_911b and DS_911b, are used to strengthen the mevalonate pathway and thus increase the GPP content, specifically:
[0068] US_911b / FBA1p-EfMvaE-VPS13t / PGK1p-EfMvaS A110G -TEF2t / TEF1p-IDI1-CYC1t / DS_911b;
[0069] The fourth expression cassette includes constitutive promoters TPI1p, TEF2p, TEF1p; terminators GND2t, ENO2t, CYC1t; enzymes ERG12, ERG8, ERG19 of the mevalonate pathway and homology arms US_308a and DS_308a upstream and downstream of the insertion site, specifically:
[0070] US_308a / TPI1p-ERG12-GND2t / TEF2p-ERG8-ENO2t / TEF1p-ERG19-CYC1t / DS_308a;
[0071] The fifth expression cassette includes constitutive promoters TDH3p and TEF2p; terminators TEF1t and ENO2t; mutant isopentenyl transferase PcPT07; and mutant geranyl pyrophosphate synthase ERG20. F96W / N127W The upstream and downstream homology arms of the insertion site, US_YPRCδ15 and DS_YPRCδ15, are used to catalyze the synthesis of bakuchiol from p-coumaric acid and GPP precursor. Specifically:
[0072] US_YPRCδ15 / TDH3p-PcPT07-TEF1t / TEF2p-ERG20 F96W / N127W -ENO2t / DS_YP RCδ15.
[0073] The present invention also provides a method for constructing an engineering strain that can synthesize bakuchiol from scratch using glucose as a single carbon source, specifically:
[0074] A plurality of expression cassettes were constructed by conventional methods well known to those skilled in the art, and each expression cassette was integrated into different sites in the genome of Saccharomyces cerevisiae by homologous recombination technology to obtain the first strain that can synthesize bakuchiol de novo using glucose as a single carbon source. The expression cassette includes:
[0075] The first expression cassette includes constitutive promoters ENO2p, TDH3p, PGK1p; terminators CYC1t, TEF1t, TEF2t; enzymes AtPAL2, AtC4H, AtATR2 of the p-coumaric acid synthesis pathway and homologous arms US_911b and DS_911b upstream and downstream of the insertion site, which are used to achieve the de novo synthesis of the key precursor p-coumaric acid in Saccharomyces cerevisiae. Specifically:
[0076] US_911b / ENO2p-AtPAL2-CYC1t / TDH3p-AtC4H-TEF1t / PGK1p-AtATR2-TE F2t / DS_911b;
[0077] The second expression cassette includes constitutive promoters TDH3p, TEF2p, TPI1p; terminators TEF1t, ENO2t, GND2t; p-coumaric acid synthesis pathway enzymes FjTAL, ARO4 K229L 、ARO7 G141S and the upstream and downstream homology arms US_1014a and DS_1014a of the insertion site, which are used to relieve the negative feedback inhibition of yeast in the synthesis of amino acids phenylalanine and tyrosine and increase the production of the key precursor p-coumaric acid. Specifically:
[0078] US_1014a / TDH3p-FjTAL-TEF1t / TEF2p-ARO4 K229L -ENO2t / TPI1p-ARO7 G141S -GND2t / DS_1014a;
[0079] The third expression cassette includes constitutive promoters FBA1p, PGK1p, TEF1p; terminators VPS13t, TEF2t, CYC1t; enzymes EfMvaE and EfMvaS of the mevalonate pathway A110G , IDI1 and upstream and downstream homology arms of the insertion site US_416d, DS_416d, (the integration site of this expression cassette is different from the integration site of the third expression cassette mentioned above), specifically:
[0080] US_416d / FBA1p-EfMvaE-VPS13t / PGK1p-EfMvaS A110G -TEF2t / TEF1p-IDI1-CYC1t / DS_416d;
[0081] The fourth expression cassette includes constitutive promoters TPI1p, TEF2p, TEF1p; terminators GND2t, ENO2t, CYC1t; enzymes ERG12, ERG8, ERG19 of the mevalonate pathway and homology arms US_308a and DS_308a upstream and downstream of the insertion site, specifically:
[0082] US_308a / TPI1p-ERG12-GND2t / TEF2p-ERG8-ENO2t / TEF1p-ERG19-CYC1t / DS_308a;
[0083] The fifth expression cassette includes constitutive promoters TDH3p and TEF2p; terminators TEF1t and ENO2t; mutant isopentenyl transferase PcPT07 and mutant geranyl pyrophosphate synthase ERG20 F96W / N127W And the upstream and downstream homology arms of the insertion site US_YPRCδ15 and DS_YPRCδ15, specifically:
[0084] US_YPRCδ15 / TDH3p-PcPT07-TEF1t / TEF2p-ERG20 F96W / N127W -ENO2t / DS_YP RCδ15.
[0085] The present invention also provides a method for engineering a high-yield bakuchiol engineered strain based on the engineered strain that can synthesize bakuchiol from scratch using glucose as a single carbon source. This transformation method covers three steps, each of which is independently effective, and any one of the steps can be selected according to the purpose of the experiment. In addition, in order to achieve more efficient experimental results, these steps can also be carried out simultaneously, or implemented step by step in a predetermined order according to the specific requirements of the experimental design.
[0086] The engineered strain capable of synthesizing bakuchiol from scratch using glucose as a single carbon source is used as the first strain, and the transformation method includes the following three steps:
[0087] Step 1: knocking out the endogenous pyruvate decarboxylase PDC5 gene and the phenylpyruvate decarboxylase ARO10 gene of Saccharomyces cerevisiae from the genome of the target strain by homologous recombination technology;
[0088] Step 2: Replace the promoter of the gene encoding farnesyl pyrophosphate synthase ERG20 in the genome of the target strain with the promoter of the gene encoding squalene epoxidase ERG1 in situ by homologous recombination technology; this step can be achieved based on the following expression cassette: US_ERG20-ERG1p-DS_ERG20;
[0089] Step 3: Connect the mutant isopentenyl transferase PcPT07 encoding gene to the geranyl pyrophosphate synthase mutant ERG20 via a linker encoding gene F96W / N127W The 5' end of the coding gene is located to obtain a fusion gene fragment; an expression cassette containing the fusion gene fragment is constructed according to the fusion gene fragment, and the expression cassette containing 1 to 3 fusion gene fragments is integrated into the genome of the target strain through homologous recombination technology.
[0090] The nucleotide sequence of the gene encoding the connecting peptide is GGTGGTGGCGGTTCC, as shown in SEQ ID NO. 17. The amino acid sequence of the connecting peptide is GGGGS, as shown in SEQ ID NO. 18.
[0091] Among them, step three can be implemented based on any of the following expression cassettes:
[0092] Single copy expression cassette, containing 1 fusion gene fragment:
[0093] US_XII-2 / PGK1p-ERG20F96W / N127W-GGGGS-PcPT07t-TEF2t / DS_XII-2;
[0094] Double copy expression cassette, containing 2 fusion gene fragments:
[0095] US_XII-2 / PGK1p-ERG20F96W / N127W-GGGGS-PcPT07t-TEF2t / FBA1p-ER G20F96W / N127W-GGGGS-PcPT07t-VPS13 / DS_XII-2;
[0096] Three-copy expression cassette, containing three fusion gene fragments:
[0097] US_XII-2 / PGK1p-ERG20F96W / N127W-GGGGS-PcPT07t-TEF2t / FBA1p-ER G20F96W / N127W-GGGGS-PcPT07t-VPS13 / ENO2p-ERG20F96W / N127W-GGGG S-PcPT07t-CYC1t / DS_XII-2.
[0098] In order to more clearly illustrate the purpose and technical scheme of the present invention, the technical scheme in the embodiment of the present invention will be clearly and completely described below in conjunction with the embodiment of the present invention. Obviously, the described embodiment is a part of the embodiment of the present invention, rather than all the embodiments. Based on the embodiment of the present invention, for ordinary technicians in the field, all other embodiments obtained without any creative work precursors belong to the scope of protection of the present invention. In the embodiment of the present invention, the starting strain Saccharomyces cerevisiae BY4742 was obtained by commercial means.
[0099] Example 1
[0100] In this example, Saccharomyces cerevisiae BY4742 (Cas9 gene expression cassette has been pre-integrated in the genome) was used as the starting strain, and a Saccharomyces cerevisiae with enhanced mevalonate pathway was first constructed to enhance the supply of geranyl pyrophosphate GPP, and Saccharomyces cerevisiae BAK01 with high geranyl pyrophosphate production was obtained. Next, the mutant isopentenyl transferase PcPT07 was introduced into the genome of Saccharomyces cerevisiae BAK01 to obtain Saccharomyces cerevisiae BAK02, in order to verify the function of the mutant isopentenyl transferase PcPT07 in catalyzing the trans-geranylation of p-coumaric acid and coupling decarboxylation to generate bakuchiol.
[0101] Construction of Saccharomyces cerevisiae BAK01 with high geranyl pyrophosphate production
[0102] PCR amplification and integration of gene fragments: Using the genome of Saccharomyces cerevisiae BY4742 (GenBank: GCA_003086655.1) as a template, PCR amplification of the upstream and downstream homology arms of the 911b and 308a integration sites (respectively: US_911b, DS_911b, US_308a, DS_308a); using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR amplification of FBA1 promoter, VPS13 terminator, PGK1 promoter, TEF2 terminator, TEF1 promoter, CYC1 terminator, TPI1 promoter, GND2 terminator, TEF2 promoter, ENO2t terminator, TEF1 promoter and CYC1 terminator fragments; using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR amplification of IDI1, ERG12, ERG8 and ERG19 gene fragments. EfMvaE and EfMvaS were obtained by gene synthesis. A110G Gene fragments. The above fragments were assembled by fusion PCR and connected to the pTA2 vector by TA cloning. After the integration fragments were sequenced, the following two corresponding gene expression cassettes were obtained:
[0103] The third expression cassette:
[0104] US_911b / FBA1p-EfMvaE-VPS13t / PGK1p-EfMvaS A110G -TEF2t / TEF1p-IDI1-CYC1t / DS_911b;
[0105] Fourth expression cassette:
[0106] US_308a / TPI1p-ERG12-GND2t / TEF2p-ERG8-ENO2t / TEF1p-ERG19-CYC1t / US_308a.
[0107] The above expression cassettes were transformed into Saccharomyces cerevisiae BY4742 with sgRNA plasmids (sgRNA-911b, sgRNA-308a) respectively (it should be noted that the fourth expression cassette was integrated after the third expression cassette was integrated). After the correct integration was verified by colony PCR, the Saccharomyces cerevisiae engineered strain BAK01 with enhanced mevalonate pathway was obtained.
[0108] Verification of mutant prenyltransferase PcPT07
[0109] In this example, the conserved motifs of isopentenyl transferase, i.e., DxxxD, YxxxK, and DxxDxxGD, were first used to fish out candidate genes and conduct experimental verification in the transcriptome data of Psoralea corylifolia plants, and the isopentenyl transferase PcPT07-FL that can successfully catalyze the trans-geranylation of p-coumaric acid and coupled decarboxylation to produce bakuchiol was screened. The original amino acid sequence of the isopentenyl transferase PcPT07-FL is shown in SEQ ID NO.15.
[0110] Next, RNA from the psoralea corylifolia plant was extracted and reverse transcribed into cDNA. The mutant isopentenyl transferase PcPT07 gene fragment (sequence shown in SEQ ID NO.2) with 84 amino acids truncated at the N-terminus was amplified by PCR, and the catalytic activity of the isopentenyl transferase was significantly improved by truncation of the N-terminal signal peptide. The signal peptide of the isopentenyl transferase PcPT07-FL was predicted using the bioinformatics analysis website TargetP 2.0. Using the genome of Saccharomyces cerevisiae BY4742 as a template, multiple primers were designed to clone and construct the farnesyl synthase mutant ERG20 F96W / N127W Gene fragments; Using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR amplified the upstream and downstream homology arms of the YPRCδ15 integration site (US_YPRCδ15 and DS_YPRCδ15); Using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR amplified the TDH3 promoter and TEF1 terminator fragments. The above fragments were assembled by fusion PCR and connected to the pTA2 vector by TA cloning. After the integration fragments were sequenced, the corresponding gene expression cassette was obtained:
[0111] Fifth expression cassette:
[0112] US_YPRCδ15 / TDH3p-PcPT07-TEF1t / TEF2p-ERG20 F96W / N127W -ENO2t / DS_YP RCδ15.
[0113] The fifth expression cassette and the sgRNA plasmid (sgRNA-YPRCδ15) were transformed into Saccharomyces cerevisiae BAK01. After colony PCR verification of correct integration, Saccharomyces cerevisiae BAK02 was obtained.
[0114] Next, the function of PcPT07 was verified by culturing Saccharomyces cerevisiae BAK01 and Saccharomyces cerevisiae BAK02 and performing HPLC analysis on the fermentation products:
[0115] BAK01 and BAK02 were inoculated into 5 mL of YPD medium and cultured overnight at 30°C and 220 rpm. 600=0.2 was inoculated into 10 mL of YPD medium (100 mL conical flask) and cultured at 30°C and 220 rpm for 2 days. Centrifuged (500g, 4 min), the cells were collected, resuspended in 1 mL of YPD medium containing a final concentration of 1 mM p-coumaric acid, and then cultured under the same conditions for 1 day. After the culture was completed, an equal amount of methanol was added to the medium and vortexed to mix. The obtained sample was centrifuged at 14000 rpm for 10 min. The supernatant was filtered with a 0.22 μm filter membrane, and the filtrate was subjected to subsequent liquid phase analysis.
[0116] The fermentation product was subjected to HPLC analysis. The analysis method is as follows: reverse phase C18 chromatographic column (5μm, 4.6×150mm, Agilent). The fluidity consists of 1‰ formic acid aqueous solution (A) and acetonitrile (B). The gradient elution program is as follows: 5%-35% B, 7min; 35%-95% B, 3min; 95% B, 5min. The program running time is 5min. The flow rate is 1.0mL / min, and p-coumaric acid (p-CA) is detected at 308nm, and bakuchiol (BAK) is detected at 262nm. The liquid phase analysis conditions in the following examples are the same, so they will not be repeated later. The liquid phase analysis results are as follows Figure 2 The results showed that PcPT07 could convert p-coumaric acid to produce a new product peak with the same retention time as the bakuchiol standard (e.g. Figure 2 As shown). Rapid liquid chromatography-triple quadrupole mass spectrometry analysis showed that the molecular weight of the target compound was 455 in negative ion mode, which was consistent with the standard bakuchiol (as shown Figure 4 The product was confirmed to be bakuchiol.
[0117] In order to further confirm the function of PcPT07, the engineered strains BAK01 and BAK02 that were cultured overnight were placed in 200 mL of YPD medium (500 mL conical flask), cultured at 30°C and 220 rpm for 3 days, and then the bacterial precipitates were centrifuged for microsome extraction. The extracted microsomes were characterized by in vitro experiments. The 100 μL reaction system was as follows: 100 mM Tris HCl (pH 7.0), 100 μM p-coumaric acid, 80 μg of microsomes, 200 μM GPP, and 10 mM MgCl2. The in vitro reaction conditions were 30°C for 1 h. After the reaction was completed, an equal amount of methanol was added to terminate the reaction, the mixture was vortexed and centrifuged at maximum speed for 10 minutes. The supernatant was filtered through a 0.22 μm filter membrane for liquid phase analysis. The results are as follows. Figure 3 The results showed that, similar to the in vivo analysis results, PcPT07 could convert p-coumaric acid to produce a new product peak, which had the same retention time and UV absorption as the bakuchiol standard.
[0118] In summary, by introducing the mutant isopentenyl transferase PcPT07 from Psoralea corylifolia, the biosynthetic pathway of bakuchiol was improved, and the mutant isopentenyl transferase PcPT07 that can catalyze the trans-geranylation of p-coumaric acid and coupled decarboxylation to generate bakuchiol was identified. So far, the biosynthetic pathway of bakuchiol has been completely resolved (such as Figure 1 shown).
[0119] Example 2
[0120] In order to achieve the de novo synthesis of bakuchiol, this example uses Saccharomyces cerevisiae BY4742 (the Cas9 gene expression cassette has been pre-integrated in the genome) as the starting strain to construct Saccharomyces cerevisiae BAK03 that can stably produce bakuchiol.
[0121] The AtPAL2, AtC4H, AtATR2 and FjTAL gene fragments were obtained by gene synthesis. Using the genome of Saccharomyces cerevisiae BY4742 as a template, multiple primers were designed to clone and construct mutant ARO4 K229L and ARO7 G141S gene fragments; using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR amplified the upstream and downstream homology arms of the 1014a and 416d integration sites with a length of about 1 kbp (US_1014a, DS_1014a, US_416d, DS_416d); using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR amplified the 853 bp fragment before the start codon of the PDC5 gene (US_PDC5) and the 617 bp fragment after the stop codon (DS_PDC5), and amplified the 451 bp fragment before the start codon of the ARO10 gene (US_ARO10) and the 481 bp fragment after the stop codon (DS_ARO10); using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR amplified the ENO2 promoter and TEF2 terminator fragments; the above fragments were assembled with the fragments mentioned above by fusion PCR and connected to the pTA2 vector by TA cloning. After the integration fragments were sequenced, the corresponding gene expression cassettes and repair templates for PDC5 and ARO10 were obtained:
[0122] First expression cassette:
[0123] US_911b / ENO2p-AtPAL2-CYC1t / TDH3p-AtC4H-TEF1t / PGK1p-AtATR2-TE F2t / DS_911b;
[0124] Second expression cassette:
[0125] US_1014a / TDH3p-FjTAL-TEF1t / ENO2t-ARO4 K229L -TEF2p / TPI1p-ARO7G141S -GND2t / DS_1014a;
[0126] The third expression cassette:
[0127] US_416d / FBA1p-EfMvaE-VPS13t / PGK1p-EfMvaS A110G -TEF2t / TEF1p-IDI1-CYC1t / DS_416d;
[0128] Repair template for PDC5:
[0129] US_PDC5 / DS_PDC5;
[0130] Repair template for ARO10:
[0131] US_ARO10 / DS_ARO10;
[0132] In addition, this example also obtained the fourth expression cassette and the fifth expression cassette according to the same construction and transformation method as Example 1:
[0133] Fourth expression cassette:
[0134] US_308a / TPI1p-ERG12-GND2t / TEF2p-ERG8-ENO2t / TEF1p-ERG19-CYC1t / US_308a;
[0135] Fifth expression cassette:
[0136] US_YPRCδ15 / TDH3p-PcPT07-TEF1t / TEF2p-ERG20 F96W / N127W -ENO2t / DS_YP RCδ15.
[0137] The above expression cassette and repair template were transformed into Saccharomyces cerevisiae BY4742 (Cas9 gene expression cassette has been pre-integrated into the genome) with the corresponding sgRNA plasmid (sgRNA-911b / 1014a / 416d / PDC5 / ARO10 / 308a / YPRCδ5). After colony PCR verified that the integration was correct, Saccharomyces cerevisiae BAK03 capable of de novo synthesis of bakuchiol was obtained.
[0138] The engineered strain BAK03 was cultured in YPD medium at 30°C overnight, and then inoculated into 10mL YPD medium at OD=0.2, and cultured under the same conditions for three days. After the culture was completed, 0.5mL of bacterial solution was taken, ultrasonically disrupted, and extracted three times with an equal amount of ethyl acetate. The organic phases were combined, vacuum dried, and then re-dissolved in 200μL methanol. Liquid phase analysis was performed after 0.22μm filtration. The analysis results showed that the engineered strain BAK03 of Saccharomyces cerevisiae was able to produce p-coumaric acid and bakuchiol, with a titer of p-coumaric acid of 13.2mg / L and a titer of bakuchiol of 78.4μg / L.
[0139] Example 3
[0140] In order to increase the yield of bakuchiol, this example, based on Example 2, constructed an engineered Saccharomyces cerevisiae strain BAK04-07 that can stably and highly produce bakuchiol.
[0141] Using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR was used to extend the 807 base sequences before the ATG of squalene epoxidase ERG1 to obtain the pERG1 promoter fragment; using the genome of Saccharomyces cerevisiae BY4742 as a template, PCR was used to extend the sequence 290 bp upstream of the ATG of the start codon of ERG20 as the upstream homology arm (US_ERG20), and the ERG20 gene sequence was amplified as the downstream homology arm (DS_ERG20). The above fragments were assembled by fusion PCR and connected to the pTA2 vector by TA cloning. After the integration fragment was sequenced, the corresponding gene expression cassette, namely US_ERG20-ERG1p-DS_ERG20, was obtained.
[0142] The supplied DNA and the corresponding sgRNA plasmid (sgRNA-ERG20) were co-transformed into the Saccharomyces cerevisiae engineering strain BAK03. After colony PCR verification of correct integration, the Saccharomyces cerevisiae engineering strain BAK04 was obtained.
[0143] The fermentation method and sample treatment method were the same as those in Example 2. The fermentation results showed that BAK04 could produce 236.85 μg / L of bakuchiol, which was twice the yield of BAK03.
[0144] In order to further increase the yield of bakuchiol, this example is fused with ERG20 F96W / N127W and PcPT07 to spatially bring the substrates closer, thereby improving catalytic efficiency. F96W / N127WFusion to the N-terminus of PcPT07 to obtain a fusion gene fragment. The fusion gene fragment was assembled with the corresponding promoter and terminator by fusion PCR and connected to the pTA2 vector by TA cloning. After the integration fragment was sequenced, the corresponding gene expression cassette was obtained:
[0145] PGK1p-ERG20 F96W / N127W -GGGGS-PcPT07t-TEF2t;
[0146] FBA1p-ERG20 F96W / N127W -GGGGS-PcPT07t-VPS13;
[0147] ENO2p-ERG20 F96W / N127W -GGGGS-PcPT07t-CYC1t.
[0148] Based on the above gene expression cassette, a single-copy expression cassette, a double-copy expression cassette and a triple-copy expression cassette were constructed, which are:
[0149] Single copy expression cassette:
[0150] US_XII-2 / PGK1p-ERG20 F96W / N127W -GGGGS-PcPT07t-TEF2t / DS_XII-2;
[0151] Double copy expression cassette:
[0152] US_XII-2 / PGK1p-ERG20 F96W / N127W -GGGGS-PcPT07t-TEF2t / FBA1p-ERG20F96W / N127W-GGGGS-PcPT07t-VPS13 / DS_XII-2;
[0153] Three-copy expression cassette:
[0154] US_XII-2 / PGK1p-ERG20 F96W / N127W -GGGGS-PcPT07t-TEF2t / FBA1p-ERG20 F96W / N127W -GGGGS-PcPT07t-VPS13 / ENO2p-ERG20 F96W / N127W -GGGGS-PcPT07t-CYC 1t / DS_XII-2.
[0155] The single copy expression cassette and the sgRNA plasmid (sgRNA-XII-2) were co-transfected into Saccharomyces cerevisiae BAK04 and the correct integration was verified by colony PCR to obtain the Saccharomyces cerevisiae engineered strain BAK05.
[0156] In addition, the double-copy expression cassette and the sgRNA plasmid (sgRNA-XII-2) were co-transfected into Saccharomyces cerevisiae BAK04. After colony PCR verification of correct integration, the Saccharomyces cerevisiae engineered strain BAK06 was obtained.
[0157] In addition, the three-copy expression cassette and the sgRNA plasmid (sgRNA-XII-2) were co-transfected into Saccharomyces cerevisiae BAK04. After colony PCR verification of correct integration, the Saccharomyces cerevisiae engineered strain BAK07 was obtained.
[0158] Single clones of BAK05, BAK06 and BAK07 engineering strains on the plate were picked and placed in 5 mL YPD medium and cultured at 30°C and 220 rpm for 20 h for activation. 600 =0.2 and re-inoculated in 10mL YPD medium. Cultured at 30℃, 220rpm for 3 days. After the culture, take 500μL of bacterial solution and add 500μL of methanol. Vortex to mix and ultrasonicate for 10min. After the ultrasonicate is finished, centrifuge at 14000rpm for 10min. After the supernatant is filtered through a 0.22μm filter membrane, perform liquid phase analysis. The results are as follows:
[0159] The production of bakuchiol in BAK05, BAK06 and BAK07 were 3.67 mg / L, 7.81 mg / L and 9.27 mg / L respectively. The detailed results are shown in Table 1.
[0160] Table 1 Fermentation results of yeast engineering strains constructed in Example 2 and Example 3
[0161]
[0162] The method for constructing a gene expression cassette and a yeast transformation method of the present invention comprises the following specific steps:
[0163] Pretreatment method of constructed gene expression cassette fragment
[0164] Pretreatment process of yeast assembly fragments: The total amount of donor DNA fragments is 2000ng (the volume of each fragment to be added is calculated according to the molar ratio of each fragment). Mix the above fragments evenly and calculate the total volume to be added. Add 1 / 10 of the total volume of 3M sodium acetate solution. Add 2 times the total volume of pre-cooled anhydrous ethanol and mix thoroughly. Incubate at -20℃ for 20min. After the incubation, centrifuge at 4℃, 15000rpm for 10min to collect the nucleic acid precipitate. Discard the supernatant and add 100μL 70% ethanol to wash the precipitate. Centrifuge under the same conditions for 5min. After the centrifugation, discard the supernatant, add 100μL 70% ethanol to wash the precipitate and centrifuge again, and discard the supernatant. Finally, dry at room temperature for 10min, and re-dissolve the precipitate with 4μL ddH2O. The solution is stored at -20℃ for use.
[0165] Chemical transformation method of Saccharomyces cerevisiae
[0166] The present invention uses the Frozen-EZ Yeast Transformation II Kit from ZYMO Research to perform yeast transformation. The specific steps are as follows:
[0167] (1) Pick a single yeast colony from the streaked YPD plate and place it in 5 mL of YPD medium. Culture it overnight at 30°C and 220 rpm.
[0168] (2) The next day, take 100 μL of overnight culture solution and culture it in 10 mL YPD medium under the same conditions until OD 600 =0.8-1.0. Take 500 μL of bacterial solution, centrifuge the cells at 500×g for 4 min, and discard the supernatant;
[0169] (3) Add 500 μL of EZ1 solution to resuspend the cells, centrifuge under the same conditions, and discard the supernatant;
[0170] (4) Add 50 μL of EZ2 solution to resuspend the cells to obtain yeast competent cells;
[0171] (5) Mix 4 μL of donor DNA fragment, 1 μL of sgRNA plasmid (about 500 ng) and 50 μL of yeast competent cells, add 500 μL of EZ3 solution, and mix thoroughly;
[0172] Incubate at 30°C for 60 min, flicking the solution every 20 min to mix it evenly;
[0173] Take 200 μL of the solution and spread it on the corresponding amino acid-deficient plates. After the plates are dried, they are inverted and cultured in a 30°C incubator for 4-6 days.
[0174] Integration of Cas9 gene expression cassette
[0175] In order to facilitate the subsequent use of CRISPR / Cas9 method to perform genetic manipulation on Saccharomyces cerevisiae, the present invention integrates the Cas9 gene expression cassette into the HIS3 site of Saccharomyces cerevisiae BY4742. The specific steps are as follows: design corresponding primers to clone the Cas9 expression cassette (TEF1p-Cas9-CYC1t) from addgene#43802; design primers to clone the G418 resistance gene expression cassette (KanMX) from addgene#39296; design primers to clone the HIS3 upstream and downstream homology arms from the genome of Saccharomyces cerevisiae BY4742. According to the above-mentioned chemical transformation method, the expression cassette (US_HIS3 / TEF1-Cas9-CYC1t / KanMX / DS_HIS3) is integrated into the genome of Saccharomyces cerevisiae BY4742. And screen positive transformants on a G418YPD plate containing 500μg / mL. The positive transformants will be further verified by colony PCR. Confirm that the Cas9 expression cassette is on the genome of Saccharomyces cerevisiae.
[0176] The engineered strains of Saccharomyces cerevisiae in the above embodiments were all constructed on the basis of Saccharomyces cerevisiae BY4742 integrated with the Cas9 gene expression cassette.
[0177] Preparation method of sgRNA plasmid in the embodiment
[0178] Based on addgene #43803, replace the first 20 base sequences of the gRNA scaffold sequence by PCR amplification. The corresponding sequences of the integration sites are shown in Table 2:
[0179] Table 2 Sequence list of integration sites
[0180]
[0181] sgRNA plasmid recovery method
[0182] In order to use the plasmid for gene manipulation later, the sgRNA plasmid was recovered. The yeast strain carrying the sgRNA plasmid was inoculated into 5mL YPD medium and cultured at 30℃ and 220rpm for 12h (if the strain grows slowly, the time can be appropriately extended). After the culture is completed, 10μL of the bacterial solution was taken and added to a new 5mL YPD medium. After culturing for 12h under the same conditions, 1mL of the bacterial solution was taken and centrifuged at 500×g for 4min, the supernatant was discarded, and the bacterial precipitate was washed with 1mL ddH2O. Centrifuge under the same conditions, discard the supernatant, and then wash the bacterial precipitate with 1mL ddH2O. Centrifuge under the same conditions and discard the supernatant. Resuspend the bacterial precipitate with 1mL ddH2O. Pipette 10μL into 1mL ddH2O. Mix by blowing and taking 200μL of the solution and apply it on a YPD plate containing 5-fluoroorotic acid. After the solution is dry, invert and culture it in a 30℃ incubator for 4 days. After the culture is completed, single clones are picked and streaked on YPD plates containing 5-fluoroorotic acid and plates containing uracil-deficient synthetic medium. Incubate the plates upside down at 30°C. The sgRNA plasmid is successfully recovered only if the single clone can grow on the YPD plates containing 5-fluoroorotic acid but cannot grow on the plates containing uracil-deficient synthetic medium.
[0183] The culture medium and the components of the culture medium involved in the present invention are specifically as follows:
[0184] YPD medium: 1% Yeast Extract, 2% Tryptone, 2% Glucose. If solid plates are prepared, 2% agar powder must be added.
[0185] Uracil-deficient synthetic medium: 1.7 g / L yeast basal nitrogen source (YNB), 5 g / L ammonium sulfate, 20 g / L glucose; the following amino acids are all used in amounts of 0.1 g / L: arginine, cysteine, lysine, threonine, tryptophan, leucine, adenine; the following amino acids are all used in amounts of 0.05 g / L: aspartic acid, isoleucine, phenylalanine, proline, serine, tyrosine, valine, methionine, histidine, and 15 g / L agar powder needs to be added to prepare solid plates.
[0186] The amino acid sequence and nucleotide sequence involved in the present invention are as follows:
[0187] SEQ ID NO.1:
[0188] Name: Amino acid sequence of mutant prenyltransferase PcPT07
[0189] Sequence Type: AA
[0190] Organism source: synthetic construct
[0191] MAASGESLESHEAQHHTPETLLGSIKRFCDAFYRFSRPHVITGTAINIIVMSSLALENSSDISTKFFIGLFQAILTTIPMNLYASGLNQLTDIEIDKINKPYLPLASGEFSVRTGVIIITLCAIMSLLVGWVVGSPALFWTSFAYFVLGTVYTINLPLLRWK RYPAFAALCFFIIRGLMFHVAFFLHIQTHVFKRPMMIPKSVMFGTAFMSFFYVIIALFKDIPDIEGDKEHGVKSLTMRLGQERVFWICVSLLLMAYGGAIVVGATSSFLWSKLITVSGHALLASIFWNRANSVDLKSHEEITSLYMFMWKLFYIEYFIIPLMR
[0192] SEQ ID NO.2:
[0193] Name: Nucleotide sequence of the gene encoding mutant isopentenyl transferase PcPT07
[0194] Sequence type: DNA (other DNA)
[0195] Organism source: synthetic construct
[0196] ATGGCAGCCAGTGGTGAATCATTAGAATCTCATGAAGCTCAACATCATACTCCTGAAACCTTGTTGGGTTCTATAAAACGTTTTTGTGATGCTTTTTACAGGTTTAGTAGGCCACACGTGATAACTGGCACAGCAATAAACATAATTGTTATGTCTTCCCTTGCATTGGAGAACTCATCAGATATTTCTACGAAATTTTTTATTGGCTTGTTCCAGGCCATCCTAACTACCATTCCTATGAACCTTTACGCTTCAGGCTTGAATCAGTTAACTGACATTGAAATAGACAAGATAAATAAACCGTATCTTCCACTAGCATCGGGGGAGTTTTCTGTTAGAACTGGTGTCATTATTATTACATTGTGTGCGATTATGAGTTTATTGGTTGGATGGGTTGTAGGTTCACCAGCATTATTTTGGACTAGTTTTGCCTATTTTGTGCTAGGGACTGTTTATACAATCAATTTGCCCCTATTGAGATGGAAGAGATATCCAGCGTTTGCAGCTTTGTGCTTCTTCATTATTCGAGGGCTAATGTTTCATGTTGCCTTTTTTCTTCACATACAGACCCATGTGTTCAAGAGGCCAATGATGATTCCAAAATCAGTGATGTTTGGTACGGCATTCATGAGTTTCTTCTATGTGATTATAGCATTGTTCAAGGATATACCTGATATTGAAGGAGATAAAGAACACGGTGTTAAATCTTTGACAATGCGTTTGGGTCAGGAGCGGGTATTCTGGATTTGTGTTTCACTTCTTTTAATGGCTTATGGAGGTGCCATTGTTGTGGGAGCAACATCTTCCTTCCTCTGGAGCAAATTGATCACGGTTTCGGGACATGCTCTTCTAGCTTCAATTTTCTGGAACCGTGCCAACTCTGTTGATTTGAAAAGTCACGAAGAGATAACATCCTTATATATGTTTATGTGGAAGCTATTTTATATTGAATACTTCATAATACCTTTAATGAGATAA
[0197] SEQ ID NO.3:
[0198] Name: Mutant 3-deoxy-D-arabinoheptulose-7-phosphate synthase ARO4 K229L Nucleotide sequence encoding a gene
[0199] Sequence type: DNA (other DNA)
[0200] Organism source: synthetic construct
[0201]
[0202] SEQ ID NO.4:
[0203] Name: Chorismate mutase ARO7 G141S Nucleotide sequence of the coding gene
[0204] Sequence type: DNA (other DNA)
[0205] Organism source: synthetic construct
[0206] ATGGATTTCACAAAACCAGAAACTGTTTTAAATCTACAAAATATTAGAGATGAATTAGTTAGAATGGAGGATTCGATCATCTTCAAATTTATTGAGAGGTCGCATTTCGCCACATGTCCTTCAGTTTATGAGGCAAACCATCCAGGTTTAGAAATTCCGAATTTTAAAGGATCTTTCTTGGATTGGGCTCTTTCAAATCTTGAAATTGCGCATTCTCGCATCAGAAGATTCGAATCACCTGATGAAACTCCCTTCTTTCCTGACAAGATTCAGAAATCATTCTTACCGAGCATTAACTACCCACAAATTTTGGCGCCTTATGCCCCAGAAGTTAATTACAATGATAAAATAAAAAAAGTTTATATTGAAAAGATTATACCATTAATTTCGAAAAGAGATGGTGATGATAAGAATAACTTCTCTTCTGTTGCCACTAGAGATATAGAATGTTTGCAAAGCTTGAGTAGGAGAATCCACTTTGGCAAGTTTGTTGCTGAAGCCAAGTTCCAATCGGATATCCCGCTATACACAAAGCTGATCAAAAGTAAAGATGTCGAGGGGATAATGAAGAATATCACCAATTCTGCCGTTGAAGAAAAGATTCTAGAAAGATTAACTAAGAAGGCTGAAGTCTATGGTGTGGACCCTACCAACGAGTCAGGTGAAAGAAGGATTACTCCAGAATATTTGGTAAAAATTTATAAGGAAATTGTTATACCTATCACTAAGGAAGTTGAGGTGGAATACTTGCTAAGAAGGTTGGAAGAGTAA
[0207] SEQ ID NO.5:
[0208] Name: Mutant mevalonate synthase EfMvaS A110G Nucleotide sequence encoding genes Sequence type: DNA (other DNA)
[0209] Organism source: synthetic construct
[0210]
[0211] SEQ ID NO.6:
[0212] Name: Target sequence for integration site 911b
[0213] Sequence type: DNA (other DNA)
[0214] Organism source: synthetic construct
[0215] GTAATATTGTCTTGTTTCCC
[0216] SEQ ID NO.7:
[0217] Name: Target sequence of integration site 308a Sequence type: DNA (other DNA) Organism source: synthetic construct CACTTGTCAAACAGAATATA SEQ ID NO.8:
[0218] Name: Target sequence of integration site YPRCδ5 Sequence type: DNA (other DNA) Organism source: synthetic construct AATCCGAACAACAGAGCATA SEQ ID NO.9:
[0219] Name: Target sequence of integration site 1014a Sequence type: DNA (other DNA) Organism source: synthetic construct TTATGTGCGTATTGCTTTCA SEQ ID NO.10:
[0220] Name: Target sequence of integration site 416d Sequence type: DNA (other DNA) Organism source: synthetic construct TAGTGCACTTACCCCACGTT SEQ ID NO.11:
[0221] Name: Target sequence of integration site XII-2 Sequence type: DNA (other DNA) Organism source: synthetic construct TGAAACTCTAATCCTACTAT SEQ ID NO.12:
[0222] Name: Target sequence of integration site PDC5 Sequence type: DNA (other DNA) Organism source: synthetic construct AGCATCCAACAATTTTTGCA SEQ ID NO.13:
[0223] Name: Target sequence of integration site ARO10 Sequence type: DNA (other DNA) Organism source: synthetic construct
[0224] CCTTCAAACAAAATTAATCT
[0225] SEQ ID NO.14:
[0226] Name: Target sequence of integration site ERG20
[0227] Sequence type: DNA (other DNA)
[0228] Organism source: synthetic construct
[0229] CGAAGTCAGCTTCTTCTCGT
[0230] SEQ ID NO.15:
[0231] Name: Amino acid sequence of isopentenyl transferase PcPT07-FL
[0232] Sequence Type: AA
[0233] Organism source: synthetic construct
[0234] MASMLFLGSLPLASSANYIGRSTRSKKCTESYHATSYITTASWNKTEKIQHEYANMRHRQHNLKHNYGGIEGVSTCEDWARNFVVNAASGESLESHEAQHHTPETLLGSIKRFCDAFYRFSRPHVITGTAINIIVMSSLALENSSDISTKFFIGLFQAILTTIPMNLYASGLNQLTDIEIDKINKPYLPLASGEFSVRTGVIIIT LCAIMSLLVGWVVGSPALFWTSFAYFVLGTVYTINLPLLRWKRYPAFAALCFFIIRGLMFHVAFFLHIQTHVFKRPMMIPKSVMFGTAFMSFFYVIIALFKDIPDIEGDKEHGVKSLTMRLGQERVFWICVSLLLMAYGGAIVVGATSSFLWSKLITVSGHALLASIFWNRANSVDLKSHEEITSLYMFMWKLFYIEYFIIPLMR
[0235] SEQ ID NO.16:
[0236] Name: Fusion gene fragment (geranyl pyrophosphate synthase mutant ERG20 F96W / N127W and truncated isopentenyl transferase PcPT07)
[0237] Sequence type: DNA (other DNA)
[0238] Organism source: synthetic construct
[0239]
[0240] SEQ ID NO.17:
[0241] Name: Nucleotide sequence of the connecting peptide encoding gene
[0242] Sequence type: DNA (other DNA)
[0243] Organism source: synthetic construct
[0244] GGTGGTGGCGGTTCC
[0245] SEQ ID NO.18:
[0246] Name: Amino acid sequence of the connecting peptide
[0247] Sequence Type: AA
[0248] Organism source: synthetic construct
[0249] GGGGS.
[0250] Finally, it should be noted that the above embodiments are only used for the technical solutions of the present invention, rather than limiting the present invention. Although the present invention has been described in detail with reference to the above embodiments, it should be understood by those skilled in the art that they can still modify the technical solutions described in the above embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. An engineered strain of Saccharomyces cerevisiae producing bakuchiol, characterized in that: The engineered strain of Saccharomyces cerevisiae overexpresses genes in the geranyl pyrophosphate synthesis pathway, genes in the p-coumaric acid synthesis pathway, and a gene encoding a mutant isopentenyl transferase PcPT07; The geranyl pyrophosphate synthesis pathway genes include the gene encoding acetoacetyl-CoA thiolase / HMG-CoA reductase EfMvaE from Enterococcus faecalis and the mutant mevalonate synthase EfMvaS A110G The encoding gene, as well as the yeast-derived isopentenyl diphosphate isomerase IDI1 encoding gene, phosphomevalonate kinase ERG8 encoding gene, diphosphomevalonate decarboxylase ERG19 encoding gene, mevalonate kinase ERG12 encoding gene and geranyl pyrophosphate synthase mutant ERG20 F96W / N127W Coding genes; The p-coumaric acid synthesis pathway genes include the phenylalanine ammonia lyase AtPAL2 encoding gene, the cinnamic acid-4-hydroxylase AtC4H encoding gene and the P450 reductase AtATR2 encoding gene from Arabidopsis thaliana, the tyrosine ammonia lyase FjTAL encoding gene from Flavobacterium truncatum, and the mutant 3-deoxy-D-arabinoheptulose-7-phosphate synthase ARO4 from Saccharomyces cerevisiae. K229L Chorismate mutase ARO7 G141S Coding gene.
2. The engineered strain of Saccharomyces cerevisiae producing bakuchiol according to claim 1, characterized in that: The engineered strain of Saccharomyces cerevisiae has the ability to generate bakuchiol de novo using glucose as a substrate; the mutant isopentenyl transferase PcPT07 is a truncated isopentenyl transferase PcPT07-FL, the truncation range is the first 84 amino acid sequences at the N-terminus, and the source of the isopentenyl transferase PcPT07-FL is psoralea corylifolia.
3. The engineered strain of Saccharomyces cerevisiae producing bakuchiol according to claim 2, characterized in that: The engineered strain of Saccharomyces cerevisiae is introduced with the mutant isopentenyl transferase PcPT07 encoding gene by at least one of the following integration methods: a: Integration of mutant isopentenyl transferase PcPT07 encoding gene; b: Integrate 1 to 3 fusion gene fragments, wherein the fusion gene fragment is mainly composed of the mutant isopentenyl transferase PcPT07 encoding gene and the geranyl pyrophosphate synthase mutant ERG20 through a connecting peptide encoding gene. F96W / N127W The coding genes are connected.
4. The engineered strain of Saccharomyces cerevisiae producing bakuchiol according to claim 2 or 3, characterized in that: The amino acid sequence of the mutant isopentenyl transferase PcPT07 is shown in SEQ ID NO.
1.
5. The engineered strain of Saccharomyces cerevisiae producing bakuchiol according to claim 1, characterized in that: The engineered strain of Saccharomyces cerevisiae is also transformed by at least one of the following transformation methods: a) The endogenous pyruvate decarboxylase PDC5 and phenylpyruvate decarboxylase ARO10 encoding genes were knocked out; b) The promoter of the gene encoding farnesyl pyrophosphate synthase ERG20 was replaced in situ with the promoter of the gene encoding squalene epoxidase ERG1.
6. The engineered strain of Saccharomyces cerevisiae producing bakuchiol according to claim 1, characterized in that: The engineering strain of Saccharomyces cerevisiae is classified and named as Saccharomyces cerevisiae BAK07, and its accession number is CGMCCNO.31081.
7. A method for constructing an engineered strain of Saccharomyces cerevisiae producing bakuchiol according to any one of claims 1 to 6, characterized in that: The construction method specifically comprises: constructing multiple expression cassettes, integrating each expression cassette into the genome of Saccharomyces cerevisiae by homologous recombination technology to obtain a first strain, and using the first strain as the engineering strain; The expression cassette includes a first expression cassette, a second expression cassette, a third expression cassette, a fourth expression cassette and a fifth expression cassette; the first expression cassette includes a phenylalanine ammonia lyase AtPAL2 encoding gene, a cinnamic acid-4-hydroxylase AtC4H encoding gene and a P450 reductase AtATR2 encoding gene; the second expression cassette includes a tyrosine ammonia lyase FjTAL encoding gene, a mutant 3-deoxy-D-arabinoheptulose acid-7-phosphate synthase ARO4 K229L Chorismate mutase ARO7 G141S encoding gene; the third expression cassette comprises the acetoacetyl-CoA thiolase / HMG-CoA reductase EfMvaE encoding gene, mutant mevalonate synthase EfMvaS A110G The fourth expression cassette comprises a gene encoding mevalonate kinase ERG12, a gene encoding phosphomevalonate kinase ERG8, and a gene encoding diphosphomevalonate decarboxylase ERG19; the fifth expression cassette comprises a mutant geranyl pyrophosphate synthase ERG20 F96W / N127W Encoding gene and mutant isopentenyl transferase PcPT07 encoding gene.
8. The method for constructing an engineered strain of Saccharomyces cerevisiae according to claim 7, characterized in that: The construction method further comprises the following steps: knocking out the endogenous pyruvate decarboxylase PDC5 encoding gene and the phenylpyruvate decarboxylase ARO10 encoding gene of Saccharomyces cerevisiae in the first strain by homologous recombination technology to obtain a second strain; The promoter of the gene encoding farnesyl pyrophosphate synthase ERG20 in the genome of the second strain is replaced in situ with the promoter of the gene encoding squalene epoxidase ERG1 by homologous recombination technology to obtain a third strain; The mutant isopentenyl transferase PcPT07 encoding gene is linked to the geranyl pyrophosphate synthase mutant ERG20 through a linker peptide encoding gene. F96W / N127W The coding genes are connected to obtain a fusion gene fragment; the expression cassette containing 1 to 3 of the fusion gene fragments is integrated into the genome of the third strain through homologous recombination technology to obtain a fourth strain, and the fourth strain is used as the brewer's yeast engineering strain.
9. Use of an engineered strain of Saccharomyces cerevisiae producing bakuchiol as claimed in any one of claims 1 to 6 or an engineered strain of Saccharomyces cerevisiae constructed by the construction method as claimed in any one of claims 7 to 8, characterized in that: It is used to produce bakuchiol using glucose as substrate and p-coumaric acid as intermediate by catalyzing the trans-geranylation of p-coumaric acid and coupled decarboxylation.
10. A method for producing bakuchiol using the engineered strain of Saccharomyces cerevisiae producing bakuchiol as claimed in any one of claims 1 to 6 or the engineered strain of Saccharomyces cerevisiae constructed by the construction method as claimed in any one of claims 7 to 8, characterized in that: The engineered strain of Saccharomyces cerevisiae is cultured in a fermentation medium to obtain a fermentation culture, and the fermentation culture is extracted and separated to obtain bakuchiol.
Citation Information
Patent Citations
Genetically engineered bacterium for synthesizing p-coumaric acid and derivatives thereof as well as construction method and application of genetically engineered bacterium
CN116731885A
P-coumaric acid production strain as well as construction method and application thereof
CN117384817A
Genetically engineered bacterium for synthesizing 4-coumaric acid and derivatives thereof as well as construction method and application of genetically engineered bacterium
CN117737107A
Esters of retinoids and bakuchiol and preparations thereof
CN118076584A
Saccharomyces cerevisiae engineering strain for producing geranyl geraniol and application of saccharomyces cerevisiae engineering strain
CN118460393A
Cited By
Recombinant yeast for producing bakuchiol as well as construction method and application of recombinant yeast
CN119842510A
Pichia pastoris engineering bacterium for synthesizing bakuchiol from de novo by converting methanol as well as construction and application of pichia pastoris engineering bacterium
CN120944729A
Pichia pastoris engineering bacteria for converting methanol to synthesize bakuchiol from scratch and construction and application thereof
CN120944729B
Saccharomyces cerevisiae engineering bacteria for producing psoralen as well as construction method and application of saccharomyces cerevisiae engineering bacteria
CN121227551A
